Identification | Back Directory | [Name]
3-Pyridinecarbonitrile, 2-[4-[2-[[(2S)-2-hydroxy-3-[2-(2-thienyl)phenoxy]propyl]amino]-2-methylpropyl]phenoxy]-, (2E)-2-butenedioate (2:1) (salt) | [CAS]
391926-19-5 | [Synonyms]
Lubabegron fumarate 3-Pyridinecarbonitrile, 2-[4-[2-[[(2S)-2-hydroxy-3-[2-(2-thienyl)phenoxy]propyl]amino]-2-methylpropyl]phenoxy]-, (2E)-2-butenedioate (2:1) (salt) | [EINECS(EC#)]
691-417-2 | [Molecular Formula]
C33H33N3O7S | [MOL File]
391926-19-5.mol | [Molecular Weight]
615.7 |
Hazard Information | Back Directory | [Uses]
Lubabegron (LY-488756) fumarate is an antagonist of the adrenergic receptor (β-AR). Lubabegron fumarate can antagonize the stimulatory effects of β1-AR and β2-AR agonists on lipase respectively[1]. | [References]
[1] Hwang JH, et al. Lubabegron fumarate acts as a β-adrenergic receptor antagonist in cultured bovine intramuscular and subcutaneous adipocytes. J Anim Sci. 2022 Mar 1;100(3):skac052. DOI:10.1093/jas/skac052 |
|
|